l General Information |
Product Name | CCG215022 |
General description | CCG215022 is a G protein-coupled receptor kinases (GRKs) inhibitor. |
Synonym | 4-[4-fluoro-3-(pyridin-2-ylmethylcarbamoyl)phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro 1H-pyrimidine-5-carboxamide; EX-A1071 |
Purity | ≥98%(HPLC) | CAS Number | 1813527-81-9 |
Formula | C26H22FN7O3 | Molecular Weight | 499.506 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
l Biological Information |
Biochem/Physiol Actions | CCG215022 is a G protein-coupled receptor kinases (GRKs) inhibitor. |
l Packaging & Storage |
Packaging | 5mg; 25mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
